Home › Geographic Atrophy › Missouri
Geographic Atrophy clinical trials in Missouri
5 studies for Geographic Atrophy are looking for participants at sites in Missouri.
Cities in Missouri
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- The Retina Institute, St Louis
RecruitingPhase 2/3
Ages 60 and older · All sexes · Updated Sep 30, 2026 · NCT06635148A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Retina Research Institute, LLC, St Louis
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Sep 18, 2026 · NCT06541704A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
- The Retina Institute, St Louis
RecruitingPhase 2
Ages 50 and older · All sexes · Updated Sep 15, 2026 · NCT05626114Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- The Retina Institute, St Louis
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Sep 10, 2026 · NCT06659445SGLT2 Inhibitors in Geographic Atrophy
- Washington University, St Louis
RecruitingPhase 2
Ages 50 and older · All sexes · Updated Aug 26, 2026 · NCT07174687From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.